EC Healthcare (HKG:2138)
Hong Kong · Delayed Price · Currency is HKD 0.4200
-0.0050 (-1.18%)
Aug 12, 2026, 3:52 PM HKT
EC Healthcare Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,770 | 3,770 | 4,140 | 4,211 | 3,875 | 2,920 |
Revenue Growth | -5.93% | -8.94% | -1.68% | 8.66% | 32.74% | 40.33% |
Gross Profit Gross Profit Growth | 1,113 | 1,113 | 1,250 | 1,330 | 1,261 | 1,185 |
Operating Income Operating Income Growth | 7.72 | 7.72 | -8.11 | 109.58 | 119.04 | 331.67 |
Net Income Net Income Growth | -402.72 | -402.72 | -167.19 | -18.95 | 69.65 | 197.5 |
Earnings Per Share EPS Growth | -0.34 | -0.34 | -0.14 | -0.02 | 0.06 | 0.17 |
EPS Growth | - | - | - | - | -64.88% | -10.16% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Aesthetic Medical, Beauty and Wellness Aesthetic Medical, Beauty and Wellness Growth | 1,323 | 1,323 | 1,296 | 1,309 | 1,102 | 1,091 |
Veterinary and Other Veterinary and Other Growth | 368.86 | 368.86 | 343.34 | 286.5 | 244.73 | 152.94 |
Medical Medical Growth | 2,223 | 2,223 | 2,562 | 2,638 | 2,547 | 1,689 |
Inter-Segment Inter-Segment Growth | -144.97 | -144.97 | -60.87 | -22.83 | -18.6 | -13.6 |
Total Total Growth | 3,770 | 3,770 | 4,140 | 4,211 | 3,875 | 2,920 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,010 | 1,010 | 1,093 | 634.48 | 760.19 | 913.74 |
Total Debt Total Debt Growth | 1,258 | 1,258 | 1,343 | 1,604 | 1,532 | 941.11 |
Net Cash (Debt) Net Cash Growth | -248.23 | -248.23 | -250.04 | -969.21 | -772.08 | -27.37 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.21 | -0.21 | -0.21 | -0.82 | -0.65 | -0.02 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 606.56 | 606.56 | 743.24 | 689.1 | 605.28 | 608.36 |
Capital Expenditures CapEx Growth | -58.69 | -58.69 | -57.17 | -161.22 | -411.01 | -260.27 |
Free Cash Flow Free Cash Flow Growth | 547.87 | 547.87 | 686.07 | 527.88 | 194.27 | 348.09 |
Free Cash Flow Growth | -0.42% | -20.14% | 29.97% | 171.73% | -44.19% | -28.22% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 29.51% | 29.51% | 30.19% | 31.59% | 32.55% | 40.60% |
Operating Margin | 0.21% | 0.21% | -0.20% | 2.60% | 3.07% | 11.36% |
Pretax Margin | -10.88% | -10.88% | -2.44% | 0.40% | 3.51% | 11.01% |
Profit Margin | -10.68% | -10.68% | -4.04% | -0.45% | 1.80% | 6.77% |
FCF Margin | 14.53% | 14.53% | 16.57% | 12.54% | 5.01% | 11.92% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.010 | 0.005 | 0.100 | 0.144 |
Dividend Per Share Growth | 100.00% | -95.00% | -30.56% | -9.43% |
Dividend Yield | 1.45% | 0.39% | 1.64% | 1.80% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | - | 106.69 | 49.76 |
Forward PE | - | 28.00 | 30.67 | 11.82 | 23.04 | 21.87 |
P/FCF Ratio | 0.92 | 1.00 | 1.19 | 2.94 | 38.25 | 28.23 |
PS Ratio | 0.13 | 0.14 | 0.20 | 0.37 | 1.92 | 3.37 |